NO20051461L - lnhaleringssammensetning - Google Patents

lnhaleringssammensetning

Info

Publication number
NO20051461L
NO20051461L NO20051461A NO20051461A NO20051461L NO 20051461 L NO20051461 L NO 20051461L NO 20051461 A NO20051461 A NO 20051461A NO 20051461 A NO20051461 A NO 20051461A NO 20051461 L NO20051461 L NO 20051461L
Authority
NO
Norway
Prior art keywords
microns
diameter
less
lactose particles
mixture
Prior art date
Application number
NO20051461A
Other languages
Norwegian (no)
Inventor
Xian-Ming Zeng
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051461(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of NO20051461L publication Critical patent/NO20051461L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en tørrpulverinhalereringssammensetning som innbefatter. medikamentpartikler og en blanding av laktosepartikler med en VMD på mellom ca. 70 og 120 mikron og en diameter på mindre enn 250 mikron, hvor blandingen er kjennetegnet ved at opp til 96 vekt-% av laktosepartiklene er mindre enn 150 mikron i diameter, og hvori opp til 25 vekt-% av laktosepartiklene er mindre enn 5 mikron i diameter. Sammensetningene tilveiebringer en mer nøyaktig, enhetlig og. konsistent dispersjon når den for eksempel anvendes med en multidose tørrpulveirnhalerer.Også beskrevet er fremgangsmåter for anvendelse av sammensetningene ifølge oppfinnelsen.The present invention provides a dry powder inhalation composition which includes. drug particles and a mixture of lactose particles with a VMD of between approx. 70 and 120 microns and a diameter of less than 250 microns, wherein the mixture is characterized in that up to 96% by weight of the lactose particles are less than 150 microns in diameter, and in which up to 25% by weight of the lactose particles are less than 5 microns. in diameter. The compositions provide a more accurate, uniform and. consistent dispersion when used, for example, with a multidose dry powder inhaler. Also described are methods of using the compositions of the invention.

NO20051461A 2002-08-21 2005-03-18 lnhaleringssammensetning NO20051461L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219513A GB0219513D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including coarse carrier
PCT/US2003/026385 WO2004017914A2 (en) 2002-08-21 2003-08-21 Inhalation composition

Publications (1)

Publication Number Publication Date
NO20051461L true NO20051461L (en) 2005-05-20

Family

ID=9942746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051461A NO20051461L (en) 2002-08-21 2005-03-18 lnhaleringssammensetning

Country Status (8)

Country Link
BR (1) BRPI0313647A2 (en)
CA (1) CA2499273C (en)
ES (1) ES2371601T3 (en)
GB (1) GB0219513D0 (en)
NO (1) NO20051461L (en)
TN (1) TNSN05047A1 (en)
WO (1) WO2004017914A2 (en)
ZA (1) ZA200502177B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
LT2708225T (en) 2004-04-23 2019-04-10 Cydex Pharmaceuticals, Inc. DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
CN104177448A (en) 2005-02-10 2014-12-03 葛兰素集团有限公司 Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB0605723D0 (en) * 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
WO2008134817A1 (en) * 2007-05-03 2008-11-13 The University Of Sydney Composite carriers for dry powder inhalation therapy
TR201105367A2 (en) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut A dry powder formulation with improved flow properties.
TR201205852A2 (en) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Improved new dry powder formulation.
GEP201706672B (en) 2012-07-05 2017-05-25 Arven Ilac Sanayi Ve Ticaret As Dry powder inhaler compositions comprising long acting muscorinic antagonists
EP2874928B1 (en) 2012-07-19 2016-06-15 Adamis Pharmaceuticals Corporation Powder feeding apparatus
JP6251667B2 (en) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 Tablet-type immediate release preparation and method for producing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
JP2002532405A (en) * 1998-12-11 2002-10-02 ファルマヘミー ベー．フェー． Opioid inhalation preparation
AU757008B2 (en) 2000-10-12 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel tiotropium-containing inhalation powder
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling

Also Published As

Publication number Publication date
WO2004017914A8 (en) 2005-07-07
WO2004017914A3 (en) 2004-04-29
BRPI0313647A2 (en) 2019-02-19
WO2004017914A2 (en) 2004-03-04
CA2499273C (en) 2011-06-21
ES2371601T3 (en) 2012-01-05
ZA200502177B (en) 2006-05-31
CA2499273A1 (en) 2004-03-04
TNSN05047A1 (en) 2007-05-14
GB0219513D0 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
NO20051461L (en) lnhaleringssammensetning
DE602005025083D1 (en)
UA86056C2 (en) Bazedoxifene acetate solid dispersion formulations, process for the preparation thereof (variants) and use thereof (variants)
TNSN07195A1 (en) Potentiators of glutamate receptors
NO20062798L (en) Use of an aqueous dispersion of at least one biodegradable polymer containing at least one stabilizing agent to prepare an aqueous film-forming composition
EA200501363A1 (en) COMPOSITION FOR THE INHALER, GIVING THE MERGENE DOSE OF THE PREPARATION, USING HYDROFLUORALKANES AS PROPELLANTS
MXPA05013059A (en) 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists.
MXPA05010137A (en) Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists.
AU2003246811A1 (en) Terphenyl derivatives, preparation thereof, compositions containing same
ATE496884T1 (en) SULPHONYLAMINOACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS
HK1073861A1 (en) Refrigerant compositions
MXPA05010496A (en) Positive allosteric modulators of the nicotinic acetylcholine receptor.
WO2005032464A3 (en) Phenyl pyrrolidine ether tachykinin receptor antagonists
WO2007073303A3 (en) Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
ATE520405T1 (en) INHALATION COMPOSITION
DK1077609T3 (en) Method for using cellobiose dehydrogenase in baking
NO20072005L (en) New heterocyclic amides
AU2001232556A1 (en) Pyrimidine compounds and their use as modulators of chemokine receptor activity
WO2008147812A3 (en) 4' substituted compounds having 5-ht6 receptor affinity
WO2005074884A3 (en) Sustained release pharmaceutical composition of indapamide
MXPA04000106A (en) Aqueous compositions comprising a chemical microgel associated with an aqueous polymer.
HUP0402183A2 (en) Liquid yeast compositions
MXPA04005151A (en) Therapeutic compounds.
MXPA05011677A (en) Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors.
TW200706173A (en) Oral composition comprising carbamylating agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application